Skip to content
Review Open access

A Systematic Review of Data Science in Early Voice‐Based Detection of Parkinson's and Amyotrophic Lateral Sclerosis Neurodegenerative Diseases

Aug 2026 · WIREs Data Mining and Knowledge Discovery · Vol 16 · 0 citations · 30 references

TL;DR

The potential of AI to analyze speech biomarkers for accurate early detection and diagnosis is reviewed, highlighting the need for future research on the development of robust, adaptive models that can accommodate data errors and remain fair and private across AI‐based diagnostics.

Abstract

Recent studies have shown that voice analysis provides a feasible, non‐invasive diagnostic alternative for the early detection of neurodegenerative diseases (NDs), such as Parkinson's disease (PD) and Amyotrophic Lateral Sclerosis (ALS), using Artificial Intelligence (AI), primarily machine learning models (MLs) that can be integrated into complex clinical decision support systems (CDSSs). Although significant progress has been made, several computational challenges remain, including dataset variability, noisy and incomplete input data, and the need for robust generalization across linguistic and demographic differences. To overcome these issues, system and model reliability must be improved through extensive testing under realistic conditions and integration with clinical workflows. This comprehensive study reviews the potential of AI to analyze speech biomarkers for accurate early detection and diagnosis. Improvements over traditional methods have been achieved through the use of Convolutional Neural Networks (CNNs), Recurrent Neural Networks (RNNs), Ensemble Methods (EMs), and diverse hybrid models. However, adoption of these models in real clinical practice is limited by challenges in standardization and effective real‐world applicability. Effective adoption of highly efficient AI‐based voice analysis in clinical practice requires standardized methods, collaboration among specialists from different disciplines, and evidence from real clinical trials. Physicians require comprehensive explanations of AI models to develop confidence in AI‐powered diagnostic tools. Explainable Artificial Intelligence (XAI) applications for neurodegenerative disease diagnosis remain underexplored in research, despite the need for healthcare practitioners to understand diagnostic predictions. Our study provides insights for researchers, software developers, and clinical practitioners, highlighting the need for future research on the development of robust, adaptive models that can accommodate data errors and remain fair and private across AI‐based diagnostics. Future research must build transparent AI models able to achieve high accuracy alongside interpretability standards for standard medical practice deployment. The review also systematically evaluates the quality of the data underlying the models that are reported, including the adequacy of the sample size, class balance, linguistic diversity, and recording conditions.

Read PDF

Similar papers

Open access Aug 2026

Large Language and Ensemble Powered Enhanced Parkinson's Detection Model

A novel ensemble-driven machine learning framework that leverages acoustic features from speech signals for early PD detection and incorporates a post-diagnostic chatbot powered by a Large Language Model (LLM), enabling personalised support and guidance.

Seema Gaba, Harpreet Kaur, Arun Singh · 0 citations
Open access Nov 2026

Early Diagnosis of Parkinson's Disease Through Voice Analysis and Machine Learning

: Parkinson’s Disease (PD) is a progressive neurological disorder, and its prevalence has increased considerably in recent years. Early and accurate diagnosis plays a crucial role in effective treatment, but identifying the disease in its early stages remains challenging, especially for non-specialist clinicians. This...

Amrita Naik, Mohd Sahil Khan, Akhilesh Manoj Saraf et al. · 0 citations
Open access 2026

A Multi-Input Neural Network for Early Detection of Neurological Disordersfrom Vocal and Sleep Data

A multi-input deep neural network that integrates vocal biomarkers and clinical sleep-related features to improve diagnostic accuracy and demonstrates consistent improvements over early and late fusion strategies, demonstrating the benefit of modality-specific representation learning.

Md Shujan Shak, Nabila Rahman, Fuad Mahmud et al. · 0 citations
Sep 2026

Diagnosis and Prognosis Perspective of Parkinson's Disease Using Multimodal Artificial Intelligence

Parkinson's disease (PD) demands both accurate early diagnosis and reliable assessment of progression, yet its clinical manifestations are heterogeneous and often become evident only after substantial neurodegeneration has occurred. This paper investigates whether multimodal artificial intelligence (AI) can address the...

Ravikumar Mutyala · 0 citations
Review Open access Sep 2026

Artificial Intelligence-Related Voice and Speech Biomarkers of Alzheimer's Disease: A Systematic Review.

BACKGROUND Artificial intelligence (AI)-based voice and speech analysis is emerging as a promising, noninvasive biomarker for Alzheimer's disease (AD) and mild cognitive impairment (MCI). This study aimed to systematically review AI voice and speech models for detecting AD and MCI, and to evaluate their translational p...

Samantha Mairesse, Giovanni Briganti, J. R. Lechien · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.